132 related articles for article (PubMed ID: 15696243)
1. Gene therapy for the extension of vein graft patency: a review.
Chandiwal A; Balasubramanian V; Baldwin ZK; Conte MS; Schwartz LB
Vasc Endovascular Surg; 2005; 39(1):1-14. PubMed ID: 15696243
[TBL] [Abstract][Full Text] [Related]
2. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
3. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
Gessaroli M; Bombardi C; Giunti M; Bacci ML
J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of vein graft failure: a review.
Davies MG; Hagen PO
Eur J Vasc Endovasc Surg; 1995 Jan; 9(1):7-18. PubMed ID: 7664016
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
[TBL] [Abstract][Full Text] [Related]
6. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.
Conte MS; Lorenz TJ; Bandyk DF; Clowes AW; Moneta GL; Seely BL
Vasc Endovascular Surg; 2005; 39(1):15-23. PubMed ID: 15696244
[TBL] [Abstract][Full Text] [Related]
7. The biology of saphenous vein graft occlusion: etiology and strategies for prevention.
Bryan AJ; Angelini GD
Curr Opin Cardiol; 1994 Nov; 9(6):641-9. PubMed ID: 7819622
[TBL] [Abstract][Full Text] [Related]
8. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy to prevent occlusion of venous bypass grafts.
Bhardwaj S; Roy H; Ylä-Herttuala S
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):641-52. PubMed ID: 18510482
[TBL] [Abstract][Full Text] [Related]
10. The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program.
Carter A; Murphy MO; Halka AT; Turner NJ; Kirton JP; Murray D; Bodill H; Millar ML; Mason T; Smyth JV; Walker MG
Ann Vasc Surg; 2007 Nov; 21(6):695-703. PubMed ID: 17980793
[TBL] [Abstract][Full Text] [Related]
11. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease.
Donker JM; Ho GH; Te Slaa A; de Groot HG; van der Waal JC; Veen EJ; van der Laan L
Vasc Endovascular Surg; 2011 Oct; 45(7):598-603. PubMed ID: 21757494
[TBL] [Abstract][Full Text] [Related]
12. A clinical commentary on the article "an early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia".
Shenoy S
J Cardiovasc Transl Res; 2011 Oct; 4(5):683-4. PubMed ID: 21842342
[No Abstract] [Full Text] [Related]
13. Therapeutics of vein graft intimal hyperplasia: 100 years on.
Wallitt EJ; Jevon M; Hornick PI
Ann Thorac Surg; 2007 Jul; 84(1):317-23. PubMed ID: 17588453
[TBL] [Abstract][Full Text] [Related]
14. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
[TBL] [Abstract][Full Text] [Related]
15. Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy.
Armstrong PA; Bandyk DF; Wilson JS; Shames ML; Johnson BL; Back MR
J Vasc Surg; 2004 Oct; 40(4):724-30; discussion 730-1. PubMed ID: 15472601
[TBL] [Abstract][Full Text] [Related]
16. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic inhibition of vein graft neointimal hyperplasia.
Schachner T
J Thorac Cardiovasc Surg; 2006 May; 131(5):1065-72. PubMed ID: 16678591
[TBL] [Abstract][Full Text] [Related]
18. Molecular engineering of vein bypass grafts.
Conte MS
J Vasc Surg; 2007 Jun; 45 Suppl A():A74-81. PubMed ID: 17544027
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia.
Baek I; Bai CZ; Hwang J; Nam HY; Park JS; Kim DJ
J Vasc Surg; 2012 Mar; 55(3):806-814.e1. PubMed ID: 22226184
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for vein grafts.
Mann MJ
Curr Cardiol Rep; 2000 Jan; 2(1):29-33. PubMed ID: 10980869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
